CRL

Charles River (CRL) to Aid INADcure in Plasmid DNA Manufacture

Charles River (CRL) collaborates with INADcure Foundation on plasmid DNA manufacturing for developing treatments for INAD patients....

Charles River and INADcure Announce Gene Therapy Manufacturing Collaboration

ALDERLEY PARK, England, June 08, 2023--Charles River Laboratories International, Inc. (NYSE: CRL) and the INADcure Foundation, a nonprofit organization whose mission is to support the development of t...

Charles River Laboratories to Present at William Blair and Jefferies Conferences

WILMINGTON, Mass., June 05, 2023--Charles River Laboratories to present at William Blair and Jefferies conferences....

Charles River (CRL) to Build RightSource Lab With New Pact

Charles River (CRL) will establish a CGMP testing lab at Wheeler's factory through latest partnership....

Wheeler Bio and Charles River Laboratories Announce Agreement to Build and Operate RightSource(SM) Laboratory

Wheeler Bio, Inc., a contract development and manufacturing organization (CDMO), and Charles River Laboratories International, Inc. (NYSE: CRL) today announced an agreement to implement RightSourceSM ...

Disclaimer: The data contained in Super Surge website is not necessarily real-time nor accurate and may differ from the actual market data. Prices, volumes, ratios, charts and indicators are indicative and not appropriate for trading purposes. Super Surge doesn't bear any responsibility for any trading losses you might incur as a result of using this data.